Post Date and Author: 
- by 


Black men are more than twice as likely as their white counterparts to die from prostate cancer.

It’s the kind of survival gap we’ve seen before. The Takeaway chronicled the black-white survival divide for women with breast cancer in our six-month-long audio storytelling series, “Under Her Skin: Living with Breast Cancer.”

Today we look at the mysteries behind the prostate cancer survival divide with WNYC’s “Living Cancer” series. The series aims to go beyond the evolving science of cancer treatment in order to explore the realities of a daily life with cancer.

“One of our challenges is we don’t really understand the biological underpinnings of the higher rates that we see in black men,” says Dr. Durado Brooks, director of Prostate and Colorectal Cancers for the American Cancer Society. “This is not just African-American men, but men of West African origin around the globe have higher rates of prostate cancer and are more likely to die of the cancer.”

Dr. Brooks says that black men are also more likely to be diagnosed with prostate cancer at an earlier age, and evidence suggests that prostate cancer can be more aggressive among younger males.

“There are some things we don’t understand, but we do know that black men don’t get the same quality of treatment,” he says. “That can be because of insurance issues and lack of access. And it’s also that a lot of men are simply fearful and don’t pursue a diagnosis.”

According to Dr. Brooks, many men are hesitant to obtain a digital rectal exam, which can be used to determine abnormalities of the prostate or identify prostate cancer itself. But there are other types of screenings available, like a prostate specific antigen (PSA) level blood test.

“It’s been shown that the PSA alone is an adequate approach to screening,” he says. “The PSA plus the digital rectal exam provides a little more information. But quite frankly, even with that combination, these are not highly reliable tests. One thing that we clearly need are better screening tests.”

In addition to screenings, Dr. Brooks says that many men that do find out that they have an elevated PSA level do not follow up with doctors for biopsies and other procedures because of a fear of cancer.

But that wasn’t the case for Elzie McCord, a professor emeritus of biology at the New College of Florida. Back in 1999, he pushed to have his PSA level tested at age 50.

“Being a scientist, I knew that blacks had a higher propensity for this disease than others,” says McCord. “I went to my [general practitioner] and asked for a PSA [test] following a digital rectal exam. He said I was too young, and that I shouldn’t take the exam. I told him that I really needed a baseline.”

Three years later, McCord went back to his doctor to have his levels tested again. It was at that point in 2002 that he was diagnosed with prostate cancer.

Though McCord says that surgery was the “gold standard” at the time, he did extensive research to identify the treatment that was right for him. He wound up undergoing prostate brachytherapy, a non-surgical radiation treatment, and some 12 years later, he is now living cancer free.
However, in some ways, McCord is the exception to the rule. There are several reasons black men put off prostate exams and follow up visits—McCord says that one of those reasons is the intimacy of the screening procedure itself.
“There’s another factor with the men that I talk to,” says McCord. “They ask me what’s involved in screening. I tell them about the digital rectal exam, and some of them say that no one is going to approach that part of their body. It appears that there’s some form of homophobia there, but it doesn’t make any sense to me.”
Though others in the black community may be hesitant, Dr. Brooks says that McCord has done everything right, and he hopes that others will follow in his footsteps.